drugset / Trial / NCT06819670
A Study to Prevent Infantile Spasms Relapse
Phase 2
Recruiting
40 enrolled
University of California, Los Angeles
Pediatric Epilepsy Research Foundation · collab
RandomizedFactorialQuadruple-blindPrevention
Summary
After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.
Timeline
- Start
- 2025-05-05
- Primary completion
- 2028-02-28
- Completion
- 2028-06-30
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Famotidine | Other / unclassified | 1 mg/kg | — |
| Comparator | Prednisolone | Other / unclassified | 1 mg/kg | — |